WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H596547
CAS#: 119433-80-6
Description: Thiazolylalanine is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff.
Hodoodo Cat#: H596547
Name: Thiazolylalanine
CAS#: 119433-80-6
Chemical Formula: C6H8N2O2S
Exact Mass: 172.03
Molecular Weight: 172.200
Elemental Analysis: C, 41.85; H, 4.68; N, 16.27; O, 18.58; S, 18.62
Synonym: Thiazolylalanine; l-Thiazolylalanine; Thiazolylalanine, l;
IUPAC/Chemical Name: (S)-2-amino-3-(thiazol-4-yl)propanoic acid
InChi Key: WBZIGVCQRXJYQD-YFKPBYRVSA-N
InChi Code: InChI=1S/C6H8N2O2S/c7-5(6(9)10)1-4-2-11-3-8-4/h2-3,5H,1,7H2,(H,9,10)/t5-/m0/s1
SMILES Code: O=C(O)[C@@H](N)CC1=CSC=N1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 172.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Mennen SM, Blank JT, Tran-Dubé MB, Imbriglio JE, Miller SJ. A peptide-catalyzed asymmetric Stetter reaction. Chem Commun (Camb). 2005 Jan 14;(2):195-7. Epub 2004 Nov 29. PubMed PMID: 15724183.
2: Mennen SM, Gipson JD, Kim YR, Miller SJ. Thiazolylalanine-derived catalysts for enantioselective intermolecular aldehyde-imine cross-couplings. J Am Chem Soc. 2005 Feb 16;127(6):1654-5. PubMed PMID: 15700996.
3: Heyl DL, Dandabathula M, Kurtz KR, Mousigian C. Opioid receptor binding requirements for the delta-selective peptide deltorphin. I: Phe3 replacement with ring-substituted and heterocyclic amino acids. J Med Chem. 1995 Mar 31;38(7):1242-6. PubMed PMID: 7707326.
4: Hashimoto N, Fujioka T, Hayashi K, Odaguchi K, Toyoda T, Nakamura M, Hirano K. Renin inhibitor: relationship between molecular structure and oral absorption. Pharm Res. 1994 Oct;11(10):1443-7. PubMed PMID: 7855049.